Berkeley, CA · Founded 2021 · Privately Held (backing)
Operator of a biotechnology platform intended to increase binding affinity and improve consistency to help create personalized, precision cancer vaccines for patients of all backgrounds. Glyphic Biotechnologies is based in Berkeley, CA and was founded in 2021. Its last reported valuation was $155 million in Sep 2025. It has raised $43.8 million.
Last reported valuation
$155.0M
Oct 2026
Priced at
—
Total raised
$43.8M
Last round
—
Cap table — not yet on record
Glyphic Biotechnologies's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Glyphic Biotechnologies with a free account
·The complete investor list: 35 names
·Watch Glyphic Biotechnologies: the Monday email on marks, rounds and moves
